Polypharmacy is the simultaneous use of multiple medications. Many authors have defined polypharmacy as the simultaneous use of at least five or six medications. Others have suggested that polypharmacy should not be determined by the absolute number of medications, but rather the use of even a single medication that is not clearly indicated.
Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings.
Patients who receive proton-pump inhibitors in the hospital are at increased risk for hospital-acquired pneumonia.
The combination of a CBC and a BMP can predict death.
Obstructive sleep apnea (OSA) is inextricably linked with adverse cardiovascular events including stroke, MI, hypertension (HTN), and arrhythmia.
